Highlights Creo Medical Group PLC

Equities

CREO

GB00BZ1BLL44

Market Closed - London S.E. Other stock markets 11:35:26 2024-05-17 am EDT			5-day change	1st Jan Change
35.3 ^GBX	+6.97%		+1.58%	-23.26%

May. 15	Creo Medical on track to break even next year on strong 2023 results	AN
May. 15	Creo Medical Group PLC Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Creo Medical on track to break even next year on strong 2023 results	May. 15	AN
Creo Medical Group PLC Reports Earnings Results for the Full Year Ended December 31, 2023	May. 15	CI
ActiveOps sales up; Sancus turnover jumps	Apr. 24	AN
EARNINGS AND TRADING: Dar Global celebrates "outstanding" year	Mar. 01	AN
Creo Medical Group plc Announces Microwave Lung Ablation Update	Mar. 01	CI
Creo Medical makes "considerable strides" toward 2025 break-even goal	Feb. 07	AN
Creo Medical partners with Khalifa University in Abu Dhabi	Feb. 05	AN
Creo Medical Group plc Announces Strategic Collaboration with Khalifa University of Science and Technology	Feb. 05	CI
Creo unveils product in APAC; Unilever hires director	Jan. 31	AN
Creo Medical Group plc Announces Continued Progress on the Phased Market Release of Its Latest Device, Speedboat® UltraSlim	Jan. 31	CI
Creo Medical's Speedboat UlstraSlim device used in Latin America	Jan. 10	AN
Creo Medical Group plc Announces First Use of Speedboat UltraSlim in the USA	Dec. 15	CI
Good Energy says ZapMap expands into mainland Europe	Dec. 13	AN
Creo Medical Group PLC Announces the Initiation of Its Commercial Launch of Speedboat Ultraslim	Dec. 13	CI
Creo Medical Group plc Receives 510(K) Clearance from the Us Food & Drug Administration for Its Speedboat Ultraslim Device	Nov. 01	CI
Creo Medical Expedites Medical Endoscopy Device Launch in Europe	23-10-25	MT
Creo Medical Group plc Announces EU Launch Accelerated by 18 Months Eu Regulatory Pathway for Launch Early 2024	23-10-25	CI
Creo Medical Group PLC Announces Change of Nominated Adviser and Joint Broker from Cavendish Securities plc to Cavendish Capital Markets Limited	23-10-16	CI
Creo Medical hails Speedboat Inject device as interim loss narrows	23-09-12	AN
Earnings Flash (CREO.L) CREO MEDICAL GROUP Reports H1 Revenue GBP15.7M	23-09-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Creo Medical Group PLC

Equities

CREO

GB00BZ1BLL44

Highlights

Filters